Payments to Acquire Property, Plant, and Equipment of Ovid Therapeutics Inc. from 31 Dec 2015 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.
Summary
Ovid Therapeutics Inc. quarterly and annual Payments to Acquire Property, Plant, and Equipment in USD history and change rate from 31 Dec 2015 to 31 Mar 2025.
  • Ovid Therapeutics Inc. Payments to Acquire Property, Plant, and Equipment for the quarter ending 31 Mar 2025 was $0, a 100% decline year-over-year.
  • Ovid Therapeutics Inc. annual Payments to Acquire Property, Plant, and Equipment for 2024 was $71,000, a 78% increase from 2023.
  • Ovid Therapeutics Inc. annual Payments to Acquire Property, Plant, and Equipment for 2023 was $40,000, a 97% decline from 2022.
  • Ovid Therapeutics Inc. annual Payments to Acquire Property, Plant, and Equipment for 2022 was $1,224,379, a 565% increase from 2021.
Source SEC data
View on sec.gov
Payments to Acquire Property, Plant, and Equipment, Quarterly (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Quarterly Change (%)
Payments to Acquire Property, Plant, and Equipment, Annual (USD)
Payments to Acquire Property, Plant, and Equipment, YoY Annual Change (%)

Ovid Therapeutics Inc. Quarterly Payments to Acquire Property, Plant, and Equipment (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $0 -$19,000 -100% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q1 2024 $19,000 +$5,000 +36% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q1 2023 $14,000 -$31,935 -70% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q1 2022 $45,935 +$34,421 +299% 01 Jan 2022 31 Mar 2022 10-Q 05 May 2023 2023 Q1
Q1 2021 $11,514 -$2,625 -19% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q1 2020 $14,139 +$9,815 +227% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021 2021 Q1
Q1 2019 $4,324 -$3,257 -43% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q1 2018 $7,581 -$4,550 -38% 01 Jan 2018 31 Mar 2018 10-Q 07 May 2019 2019 Q1
Q1 2017 $12,131 -$2,522 -17% 01 Jan 2017 31 Mar 2017 10-Q 08 May 2018 2018 Q1
Q1 2016 $14,653 01 Jan 2016 31 Mar 2016 10-Q 13 Jun 2017 2017 Q1

Ovid Therapeutics Inc. Annual Payments to Acquire Property, Plant, and Equipment (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $71,000 +$31,000 +78% 01 Jan 2024 31 Dec 2024 10-K 11 Mar 2025 2024 FY
2023 $40,000 -$1,184,379 -97% 01 Jan 2023 31 Dec 2023 10-K 11 Mar 2025 2024 FY
2022 $1,224,379 +$1,040,371 +565% 01 Jan 2022 31 Dec 2022 10-K 08 Mar 2024 2023 FY
2021 $184,008 +$56,768 +45% 01 Jan 2021 31 Dec 2021 10-K 13 Mar 2023 2022 FY
2020 $127,240 +$70,084 +123% 01 Jan 2020 31 Dec 2020 10-K 15 Mar 2022 2021 FY
2019 $57,156 +$23,285 +69% 01 Jan 2019 31 Dec 2019 10-K 15 Mar 2021 2020 FY
2018 $33,871 -$5,036 -13% 01 Jan 2018 31 Dec 2018 10-K 11 Mar 2020 2019 FY
2017 $38,907 +$8,543 +28% 01 Jan 2017 31 Dec 2017 10-K 07 Mar 2019 2018 FY
2016 $30,364 -$1,718 -5.4% 01 Jan 2016 31 Dec 2016 10-K 29 Mar 2018 2017 FY
2015 $32,082 01 Jan 2015 31 Dec 2015 10-K 29 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.